The global selinjections market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases and rising geriatric population. The syringe without needle segment is expected to grow at the highest CAGR during the forecast period due to its ease of use and safety features. The global selinjections market has been segmented on the basis of type, application, and region. On the basis of type, it has been classified into syringe without needle, automatic syringe, pen type syringe and wearable syringe. On the basis of application it has been classified into hospital, clinic and pharmaceutical companies while on the basis of region it has been classified into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa (MEA).
Some Of The Growth Factors Of This Market:
- Increasing awareness about the benefits of self-injections over other modes of treatment is also driving growth in this market.
- The growing geriatric population base across the globe will also fuel demand for self-injection treatments.
- Technological advancements in drug delivery systems are expected to provide an impetus for growth in this market.
- Increasing government initiatives and investments towards research and development activities are anticipated to boost growth prospects.
Industry Growth Insights published a new data on “Self-Injections Market”. The research report is titled “Self-Injections Market research by Types (Syringe Without Needle, Automatic Syringe, Pen Type Syringe, Wearable Syringe), By Applications (Hospital, Clinic, Pharmaceutical Companies, Other), By Players/Companies Elcam Medicalcompany Overview, Bespak, Sanofi, Sandoz International Gmbh, Unilife Corporation, West Pharmaceutical Services, Pfizer, Impax Laboratories, Penjet Corporation, Crossject Needle-Free Injection Systems, Wilhelm Haselmeier Gmbh & Co. Kg, Antares Pharma, Becton, Gerresheimer Ag, Mylan N.V, Novo Nordisk, Owen Mumford, Pharmajet, Shl Group, Ypsomed, Dickinson And Company”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Self-Injections Market Research Report
By Type
Syringe Without Needle, Automatic Syringe, Pen Type Syringe, Wearable Syringe
By Application
Hospital, Clinic, Pharmaceutical Companies, Other
By Companies
Elcam Medicalcompany Overview, Bespak, Sanofi, Sandoz International Gmbh, Unilife Corporation, West Pharmaceutical Services, Pfizer, Impax Laboratories, Penjet Corporation, Crossject Needle-Free Injection Systems, Wilhelm Haselmeier Gmbh & Co. Kg, Antares Pharma, Becton, Gerresheimer Ag, Mylan N.V, Novo Nordisk, Owen Mumford, Pharmajet, Shl Group, Ypsomed, Dickinson And Company
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Self-Injections Market Report Segments:
The global Self-Injections market is segmented on the basis of:
Types
Syringe Without Needle, Automatic Syringe, Pen Type Syringe, Wearable Syringe
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Pharmaceutical Companies, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Elcam Medicalcompany Overview
- Bespak
- Sanofi
- Sandoz International Gmbh
- Unilife Corporation
- West Pharmaceutical Services
- Pfizer
- Impax Laboratories
- Penjet Corporation
- Crossject Needle-Free Injection Systems
- Wilhelm Haselmeier Gmbh & Co. Kg
- Antares Pharma
- Becton
- Gerresheimer Ag
- Mylan N.V
- Novo Nordisk
- Owen Mumford
- Pharmajet
- Shl Group
- Ypsomed
- Dickinson And Company
Highlights of The Self-Injections Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Syringe Without Needle
- Automatic Syringe
- Pen Type Syringe
- Wearable Syringe
- By Application:
- Hospital
- Clinic
- Pharmaceutical Companies
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Self-Injections Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Self-injections are injections that are given by a person themselves. This can include injections of medication, vitamins, or other substances into the skin.
Some of the key players operating in the self-injections market are Elcam Medicalcompany Overview, Bespak, Sanofi, Sandoz International Gmbh, Unilife Corporation, West Pharmaceutical Services, Pfizer, Impax Laboratories, Penjet Corporation, Crossject Needle-Free Injection Systems, Wilhelm Haselmeier Gmbh & Co. Kg, Antares Pharma, Becton, Gerresheimer Ag, Mylan N.V, Novo Nordisk, Owen Mumford, Pharmajet, Shl Group, Ypsomed, Dickinson And Company.
The self-injections market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Self-Injections Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Self-Injections Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Self-Injections Market - Supply Chain
4.5. Global Self-Injections Market Forecast
4.5.1. Self-Injections Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Self-Injections Market Size (000 Units) and Y-o-Y Growth
4.5.3. Self-Injections Market Absolute $ Opportunity
5. Global Self-Injections Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Self-Injections Market Size and Volume Forecast by Type
5.3.1. Syringe Without Needle
5.3.2. Automatic Syringe
5.3.3. Pen Type Syringe
5.3.4. Wearable Syringe
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Self-Injections Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Self-Injections Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Pharmaceutical Companies
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Self-Injections Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Self-Injections Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Self-Injections Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Self-Injections Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Self-Injections Demand Share Forecast, 2019-2026
9. North America Self-Injections Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Self-Injections Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Self-Injections Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Pharmaceutical Companies
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Self-Injections Market Size and Volume Forecast by Type
9.7.1. Syringe Without Needle
9.7.2. Automatic Syringe
9.7.3. Pen Type Syringe
9.7.4. Wearable Syringe
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Self-Injections Demand Share Forecast, 2019-2026
10. Latin America Self-Injections Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Self-Injections Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Self-Injections Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Pharmaceutical Companies
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Self-Injections Market Size and Volume Forecast by Type
10.7.1. Syringe Without Needle
10.7.2. Automatic Syringe
10.7.3. Pen Type Syringe
10.7.4. Wearable Syringe
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Self-Injections Demand Share Forecast, 2019-2026
11. Europe Self-Injections Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Self-Injections Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Self-Injections Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Pharmaceutical Companies
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Self-Injections Market Size and Volume Forecast by Type
11.7.1. Syringe Without Needle
11.7.2. Automatic Syringe
11.7.3. Pen Type Syringe
11.7.4. Wearable Syringe
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.1. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Self-Injections Demand Share, 2019-2026
12. Asia Pacific Self-Injections Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Self-Injections Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Self-Injections Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Pharmaceutical Companies
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Self-Injections Market Size and Volume Forecast by Type
12.7.1. Syringe Without Needle
12.7.2. Automatic Syringe
12.7.3. Pen Type Syringe
12.7.4. Wearable Syringe
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Self-Injections Demand Share, 2019-2026
13. Middle East & Africa Self-Injections Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Self-Injections Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Self-Injections Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Pharmaceutical Companies
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Self-Injections Market Size and Volume Forecast by Type
13.7.1. Syringe Without Needle
13.7.2. Automatic Syringe
13.7.3. Pen Type Syringe
13.7.4. Wearable Syringe
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Self-Injections Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Self-Injections Market: Market Share Analysis
14.2. Self-Injections Distributors and Customers
14.3. Self-Injections Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Elcam Medicalcompany Overview
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bespak
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sanofi
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Sandoz International Gmbh
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Unilife Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. West Pharmaceutical Services
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Pfizer
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Impax Laboratories
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Penjet Corporation
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Crossject Needle-Free Injection Systems
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Wilhelm Haselmeier Gmbh & Co. Kg
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Antares Pharma
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Becton
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Gerresheimer Ag
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Mylan N.V
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Novo Nordisk
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Owen Mumford
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Pharmajet
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Shl Group
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Ypsomed
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook